Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy West Pharmaceutical Services (WST) stocks in Canada

Learn how to easily invest in West Pharmaceutical Services stocks.

West Pharmaceutical Services is a medical instruments & supplies business based in the US. West Pharmaceutical Services stocks (WST.US) are listed on the NYSE and all prices are listed in US Dollars. Its last market close was $373.11 – a decrease of 0.89% over the previous week. West Pharmaceutical Services employs 10,065 staff and has a trailing 12-month revenue of around $2.9 billion.

How to buy stocks in West Pharmaceutical Services

  1. Compare stock trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – WST – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of stocks with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

West Pharmaceutical Services stock price (NYSE:WST)

Use our graph to track the performance of WST stocks over time.

West Pharmaceutical Services shares at a glance

Information last updated 2022-05-19.
Latest market close$300.68
52-week range$288.12 - $474.69
50-day moving average $364.61
200-day moving average $407.57
Wall St. target price$386.20
PE ratio 32.7843
Dividend yield $0.7 (0.24%)
Earnings per share (TTM) $8.97

Compare stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

1 - 6 of 6
Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Young investors 18 to 24 can get free online trades and a $0 annual account fee. Conditions apply.
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
OFFER
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get $500 in commission free trades when you fund your account with a minimum of $10,000. Conditions apply. Ends August 31st, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy West Pharmaceutical Services stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

West Pharmaceutical Services price performance over time

Historical closes compared with the close of $300.68 from 2022-05-20

1 week (2022-05-16) -0.89%
1 month (2022-04-19) -18.95%
3 months (2022-02-22) -18.54%
6 months (2021-11-23) -30.19%
1 year (2021-05-21) -9.83%
2 years (2020-05-22) 42.21%
3 years (2019-05-23) 159.07%
5 years (2017-05-23) 215.51%

Is West Pharmaceutical Services under- or over-valued?

Valuing West Pharmaceutical Services stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of West Pharmaceutical Services's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.

West Pharmaceutical Services's P/E ratio

West Pharmaceutical Services's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 33x. In other words, West Pharmaceutical Services shares trade at around 33x recent earnings.

That's relatively high compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The high P/E ratio could mean that investors are optimistic about the outlook for the shares or simply that they're over-valued.

West Pharmaceutical Services's PEG ratio

West Pharmaceutical Services's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 4.2811. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.

The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into West Pharmaceutical Services's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.

West Pharmaceutical Services's EBITDA

West Pharmaceutical Services's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $897.8 million.

The EBITDA is a measure of a West Pharmaceutical Services's overall financial performance and is widely used to measure a its profitability.

West Pharmaceutical Services financials

Revenue TTM $2.9 billion
Operating margin TTM 26.9%
Gross profit TTM $1.2 billion
Return on assets TTM 16.05%
Return on equity TTM 32.94%
Profit margin 23.76%
Book value $31.39
Market capitalisation $21.8 billion

TTM: trailing 12 months

West Pharmaceutical Services share dividends

8%

Dividend payout ratio: 8.01% of net profits

Recently West Pharmaceutical Services has paid out, on average, around 8.01% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0.24% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), West Pharmaceutical Services shareholders could enjoy a 0.24% return on their shares, in the form of dividend payments. In West Pharmaceutical Services's case, that would currently equate to about $0.7 per share.

While West Pharmaceutical Services's payout ratio might seem low, this can signify that West Pharmaceutical Services is investing more in its future growth.

West Pharmaceutical Services's most recent dividend payout was on 3 August 2022. The latest dividend was paid out to all shareholders who bought their shares by 19 July 2022 (the "ex-dividend date").

Have West Pharmaceutical Services's shares ever split?

West Pharmaceutical Services's shares were split on a 2:1 basis on 27 September 2013. So if you had owned 1 share the day before before the split, the next day you'd have owned 2 shares. This wouldn't directly have changed the overall worth of your West Pharmaceutical Services shares – just the quantity. However, indirectly, the new 50% lower share price could have impacted the market appetite for West Pharmaceutical Services shares which in turn could have impacted West Pharmaceutical Services's share price.

West Pharmaceutical Services share price volatility

Over the last 12 months, West Pharmaceutical Services's shares have ranged in value from as little as $288.12 up to $474.6883. A popular way to gauge a stock's volatility is its "beta".

WST.US volatility(beta: 1.17)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NYSE average) beta is 1, while West Pharmaceutical Services's is 1.1732. This would suggest that West Pharmaceutical Services's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

West Pharmaceutical Services overview

West Pharmaceutical Services, Inc. designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products in the Americas, Europe, the Middle East, Africa, and the Asia Pacific. It operates in two segments, Proprietary Products and Contract-Manufactured Products. The Proprietary Products segment offers stoppers and seals for injectable packaging systems; syringe and cartridge components, including custom solutions for the needs of injectable drug applications, as well as administration systems that enhance the safe delivery of drugs through advanced reconstitution, mixing, and transfer technologies; and films, coatings, washing, and vision inspection and sterilization processes and services to enhance the quality of packaging components. It also provides drug containment solutions, including Crystal Zenith, a cyclic olefin polymer in the form of vials, syringes, and cartridges; and self-injection devices, as well as a range of integrated solutions, including analytical lab services, pre-approval primary packaging support and engineering development, regulatory expertise, and after-sales technical support. This segment serves biologic, generic, and pharmaceutical drug companies. The Contract-Manufactured Products segment is involved in the design, manufacture, and automated assembly of devices used in surgical, diagnostic, ophthalmic, injectable, and other drug delivery systems, as well as consumer products.

Frequently asked questions


Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site